Promoter analysis of the rat beta(1)-adrenergic receptor gene identifies sequences involved in basal expression

被引:12
作者
Bahouth, SW [1 ]
Cui, XL [1 ]
Beauchamp, MJ [1 ]
Shimomura, H [1 ]
George, ST [1 ]
Park, EA [1 ]
机构
[1] NIPPON DENT UNIV,DEPT ORAL BIOCHEM,NIIGATA,JAPAN
关键词
D O I
10.1124/mol.51.4.620
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The beta(1)-adrenergic receptor (beta(1)-AR) mediates several functions of catecholamines in the heart, including the stimulation of heart rate and contractility. The expression of the rat beta(1)-AR gene was assessed by transiently transfecting chimeric genes containing the beta(1)-AR promoter, driving the luciferase reporter gene into various cell lines. beta(1)-AR/luciferase vectors containing 3 kb of the 5'-flanking region and extending to -126 relative to the start site of translation were expressed at high levels in ventricular myocytes, SK-N-MC cells, and HepG2 cells. The addition of 26 nucleotides from -125 to -100 to the -3311 beta(1)-AR/luciferase chimeric gene reduced expression in myocytes and SK-N-MC cells while eliminating expression in HepG2 cells. This element is located 125 base-pairs 3' to the transcriptional start site. The mutation of four nucleotides between -121 and -118 diminished the inhibitory effect of this element. The inhibitory activity of the -125 to -100 sequence was completely dependent on promoter context and positioning. In addition to this 3' element, sequences between -3311 and -2740 in the 5'-flanking region of the beta(1)-AR gene were required for the full transcriptional suppression. Using DNase I footprinting and gel mobility assays, it was determined that within the 26-bp region, rat heart nuclear proteins bound to two sites between nucleotides -123 and -112 and -106 and -100. Therefore, appropriate basal expression of the beta(1)-AR gene involves widely separated sequences 3' and 5' to the transcriptional start site.
引用
收藏
页码:620 / 629
页数:10
相关论文
共 37 条
  • [1] Ausubel FM, 1995, SHORT PROTOCOLS MOL
  • [2] BAHOUTH SW, 1991, J BIOL CHEM, V266, P15863
  • [3] BAHOUTH SW, 1994, REGULATION CELLULAR, P99
  • [4] BRASIER AR, 1992, METHOD ENZYMOL, V216, P386
  • [5] BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116
  • [6] CHARACTERIZATION OF A MOUSE BETA-1-ADRENERGIC RECEPTOR GENOMIC CLONE
    COHEN, JA
    BAGGOTT, LA
    ROMANO, C
    ARAI, M
    SOUTHERLING, TE
    YOUNG, LH
    KOZAK, CA
    MOLINOFF, PB
    GREENE, MI
    [J]. DNA AND CELL BIOLOGY, 1993, 12 (06) : 537 - 547
  • [7] CLONING AND SEQUENCE-ANALYSIS OF THE HUMAN BETA-1-ADRENERGIC RECEPTOR 5'-FLANKING PROMOTER REGION
    COLLINS, S
    OSTROWSKI, J
    LEFKOWITZ, RJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1172 (1-2) : 171 - 174
  • [8] CAMP STIMULATES TRANSCRIPTION OF THE BETA-2-ADRENERGIC RECEPTOR GENE IN RESPONSE TO SHORT-TERM AGONIST EXPOSURE
    COLLINS, S
    BOUVIER, M
    BOLANOWSKI, MA
    CARON, MG
    LEFKOWITZ, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) : 4853 - 4857
  • [9] MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR
    EMORINE, LJ
    MARULLO, S
    BRIENDSUTREN, MM
    PATEY, G
    TATE, K
    DELAVIERKLUTCHKO, C
    STROSBERG, AD
    [J]. SCIENCE, 1989, 245 (4922) : 1118 - 1121
  • [10] ESBENSHADE TA, 1992, MOL PHARMACOL, V42, P753